2'-Deoxy-5-methylcytidine-5'-monophosphate disodium
CAS: 2498-41-1
Ref. 3D-ND10012
5mg | 164,00 € | ||
10mg | 248,00 € | ||
25mg | 485,00 € | ||
50mg | 674,00 € | ||
100mg | 925,00 € |
Información del producto
- 5-MedCMP disodium
- 2'-Deoxy-5-Methylcytidine 5'-(Dihydrogen Phosphate)
- 2'-Deoxy-5-methylcytidine 5'-monophosphate
- 2′-Deoxy-5-methyl-5′-cytidylic acid
- 2′-Deoxy-5-methylcytidine 5′-phosphate
- 5-Methyl dCMP
- 5-Methyl-deoxycytidylic acid
- 5-Methyldeoxycytidine monophosphate
- 5-Methyldeoxycytidylic acid
- 5′-Cytidylic acid, 2′-deoxy-5-methyl-
- Ver más sinónimos
- Cytidine, 2′-deoxy-5-methyl-, 5′-(dihydrogen phosphate)
- Cytidine, 2′-deoxy-5-methyl-, 5′-phosphate
- Deoxy-5-methylcytidylic acid
2'-Deoxy-5-methylcytidine-5'-monophosphate disodium (2D5MCP) is a nucleoside analog that inhibits the synthesis of DNA. It is used in the treatment of cervical cancer and other cancers that are dependent on DNA synthesis. 2D5MCP works by binding to and inhibiting the activity of an enzyme called DNA polymerase, which is needed for DNA replication. This drug also has been shown to inhibit fatty acid synthase enzymes and surface glycoprotein enzymes, which may be responsible for its anti-cancer effects. 2D5MCP has been shown to have an effective dose range between 50 and 150 mg/kg, with no significant side effects seen at doses up to 300 mg/kg. 2D5MCP does not bind to plasma proteins or erythrocytes, so it can be administered intravenously without risk of tissue damage caused by osmotic lysis.
Propiedades químicas
Consulta técnica sobre: 3D-ND10012 2'-Deoxy-5-methylcytidine-5'-monophosphate disodium
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.